Daily Anesthesiology Research Analysis
Analyzed 64 papers and selected 3 impactful papers.
Summary
The most impactful papers combined mechanistic discovery with clinically consequential evidence. A preclinical study identified the H3K18 lactylation–LAG3–NLRP3 axis as a potential driver of perioperative neurocognitive disorder, while a Bayesian analysis of the MINT randomized trial supported liberal transfusion in patients with myocardial infarction and anemia. A large multicenter observational study further suggested that successful advanced airway management within 10 minutes may improve survival in pediatric out-of-hospital cardiac arrest.
Research Themes
- Perioperative neuroinflammation and epigenetic mechanisms
- Transfusion thresholds in acute myocardial infarction
- Timing of advanced airway management in pediatric cardiac arrest
Selected Articles
1. Histone H3K18 Lactylation Contributes to Perioperative Neurocognitive Disorder Through Immune Checkpoint Lymphocyte Activation Gene 3 Mediated Microglial Pyroptosis.
In a mouse model, surgery increased hippocampal lactate and H3K18 lactylation, which transcriptionally activated Lag3. Lag3 blockade or glycolysis inhibition reduced microglial NLRP3-dependent pyroptosis, neuroinflammation, and postoperative cognitive impairment, identifying the H3K18la–LAG3–NLRP3 axis as a potential therapeutic pathway.
Impact: This study proposes a previously unreported epigenetic–immune mechanism linking surgical metabolic changes to perioperative neurocognitive disorder. It also provides pharmacologically testable targets rather than only describing postoperative inflammation.
Clinical Implications: The findings support investigation of perioperative metabolic or LAG3-targeted interventions to prevent cognitive dysfunction, but they do not yet justify clinical use. Translation will require validation in human perioperative tissues and confirmation of safety and timing of intervention.
Key Findings
- Surgery increased hippocampal lactate and H3K18 lactylation in mice.
- H3K18 lactylation enriched at the Lag3 promoter and transcriptionally activated Lag3.
- Glycolysis inhibition or Lag3 blockade reduced NLRP3-dependent microglial pyroptosis and improved postoperative cognition.
Methodological Strengths
- Integrated in vivo behavioral experiments with CUT&Tag, RNA sequencing, gene silencing, and pharmacological validation.
- Examined a mechanistic chain from surgery-induced metabolism to epigenetic regulation, immune signaling, and cognitive outcome.
Limitations
- The evidence is based on mouse and BV2 microglial models, so human relevance remains unconfirmed.
- The abstract does not establish whether the interventions affect other postoperative complications or long-term cognition.
Future Directions: Future studies should validate the H3K18la–LAG3–NLRP3 pathway in human surgical patients, define the therapeutic window, and test whether targeted modulation improves durable cognitive and functional outcomes.
AIMS: This study investigates whether histone H3K18 lactylation (H3K18la) contributes to perioperative neurocognitive disorders (PND) by upregulating immune checkpoint Lymphocyte activation gene 3 (Lag3) and microglial pyroptosis, thereby aggravating neuroinflammation in the hippocampus. METHODS: Lactate levels and H3K18la expression were measured in mouse hippocampus after surgery. H3K18la downstream targets were identified by CUT&Tag and RNA-seq. After Lag3 silencing in BV2 cells, downstream pathways were screened and validated by RNA-seq and in vitro assays.
2. Restrictive vs Liberal Transfusion Strategy After Myocardial Infarction: A Post Hoc Analysis of the MINT Randomized Clinical Trial.
This Bayesian post hoc analysis of 3,504 participants from the MINT randomized trial found that a liberal transfusion strategy was associated with an estimated 1.4% to 2.4% lower risk of 30-day death or myocardial infarction than a restrictive strategy. The probability of benefit was 89.1% to 98.8%, while the possible increase in heart failure was small and uncertain.
Impact: The study addresses a common and high-stakes perioperative and critical care decision using data from a large randomized trial. Bayesian probability estimates translate trial findings into clinically interpretable uncertainty and may influence transfusion decision-making in myocardial infarction.
Clinical Implications: For patients with myocardial infarction and anemia, maintaining hemoglobin above 10 g/dL may be reasonable when individualized assessment suggests potential ischemic benefit, while clinicians should monitor for heart failure and incorporate patient preferences and comorbidity.
Key Findings
- The MINT trial included 3,504 adults with myocardial infarction and anemia across 144 sites in 6 countries.
- Compared with restrictive transfusion, the liberal strategy was associated with a 1.4% to 2.4% lower estimated risk of 30-day death or myocardial infarction.
- The probability of benefit was 89.1% to 98.8%, whereas the estimated excess heart failure risk was 0.2% to 0.6% and remained uncertain.
Methodological Strengths
- Used data from a large multicenter randomized clinical trial with ClinicalTrials.gov registration.
- Applied Bayesian analyses with noninformative, liberal-superiority, and restrictive-superiority prior beliefs to quantify uncertainty.
Limitations
- This was a post hoc analysis rather than the primary prespecified analysis of the randomized trial.
- Bayesian posterior estimates depend partly on the selected prior distributions and may not resolve all subgroup-specific treatment effects.
Future Directions: Future analyses should identify patients most likely to benefit from liberal transfusion, clarify effects across infarction type and heart failure risk strata, and integrate these findings into updated transfusion guidelines.
IMPORTANCE: The decision to transfuse a patient with myocardial infarction (MI) and anemia at a higher vs lower hemoglobin threshold must consider the potential benefit of reduced risk of 30-day death or MI and the potential risk of heart failure. OBJECTIVES: To estimate bayesian posterior risk differences and posterior probabilities that a liberal vs restrictive transfusion strategy is associated with reduced risk of 30-day death or MI and whether the probabilities exceed predefined thresholds. DESIGN, SETTING, AND PARTICIPANTS: The Myocardial Ischemia and Transfusion (MINT) trial recruited adults from April 26, 2017, to April 14, 2023, who were hospitalized with MI and anemia at 144 sites in 6 countries.
3. Early Successful Prehospital Advanced Airway Management and Outcomes in Pediatric Out-of-Hospital Cardiac Arrests.
Among 954 children with nontraumatic out-of-hospital cardiac arrest, successful advanced airway management within 10 minutes of emergency medical services arrival was associated with higher survival to hospital discharge after time-dependent propensity matching. Advanced airway management at any time was not significantly associated with survival, emphasizing that timing may be more important than the procedure alone.
Impact: This study addresses a time-critical and clinically controversial component of pediatric resuscitation. Its finding that early, rather than simply any, successful airway management may be beneficial can inform prehospital protocols and future prospective comparative studies.
Clinical Implications: Emergency medical systems should consider prioritizing rapid, high-quality airway management when indicated during pediatric cardiac arrest, while avoiding interruptions to chest compressions and other evidence-based resuscitation steps. The observational design does not establish that early airway management itself causes improved survival.
Key Findings
- The cohort included 954 pediatric patients with nontraumatic out-of-hospital cardiac arrest; 91 survived to hospital discharge.
- Successful advanced airway management within 10 minutes was associated with survival to discharge, with a risk ratio of 1.93.
- Successful advanced airway management at any time was not significantly associated with survival, with a risk ratio of 1.35 and a 95% confidence interval of 0.75 to 2.43.
Methodological Strengths
- Used a multicenter North American registry with time-dependent propensity-score matching.
- Distinguished early successful airway management from airway management performed at any time, directly addressing the timing question.
Limitations
- The retrospective observational design leaves potential for residual confounding and confounding by indication.
- The registry data may not capture airway-management quality, provider expertise, ventilation parameters, or detailed chest-compression interruptions.
Future Directions: Prospective studies and pragmatic trials should evaluate airway-management strategies together with compression quality, supraglottic versus endotracheal techniques, provider training, and neurologically favorable survival.
OBJECTIVES: While advanced airway management (AAM) is commonly performed for children with out-of-hospital cardiac arrest (OHCA), the benefit and optimal timing of AAM remains unclear. To determine whether earlier prehospital AAM is associated with patient outcomes compared with later or no AAM in children with OHCA. METHODS: Retrospective cohort study of pediatric patients (aged <18 years) with nontraumatic OHCA treated by emergency medical services (EMS), using the Resuscitation Outcomes Consortium Epidemiologic Registry-Cardiac Arrest at 10 sites in the United States and Canada from April 2011 to June 2015. The exposures are early prehospital AAM (defined as successful AAM within 10 minutes of EMS arrival) and any successful prehospital AAM.